Developing treatments for rheumatoid arthritis and osteoarthritis

Key points

  • GSK has launched phase III clinical trials for a drug designed to treat hand osteoarthritis and rheumatoid arthritis.
  • Osteoarthritis and rheumatoid arthritis are the two most common forms of arthritis.
  • The drug is based on antibody technology developed by Professor John Hamilton and Associate Professor Andrew Cook of the Faculty of Medicine, Dentistry and Health Sciences.

Find out more